- Limited efficacy of daratumumab in multiple myeloma with extramedullary disease2022 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation2019 | First Faculty of Medicine
- Identification of patients at high risk of secondary extramedullary multiple myeloma development2022 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma2015 | Faculty of Medicine in Hradec Králové
- Salvage treatment with upfront melphalan 100 mg/m(2) and consolidation with novel drugs for fulminant progression of multiple myeloma2010 | First Faculty of Medicine
- Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia2015 | Second Faculty of Medicine
- Pediatric Precursor B-Cell Lymphoblastic Malignancies: From Extramedullary to Medullary Involvement2022 | Second Faculty of Medicine
- Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome2009 | Second Faculty of Medicine
- Remission, treatment failure, and relapse in pediatric ALL: An international consensus of the Ponte-di-Legno Consortium2022 | Second Faculty of Medicine
- Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL2023 | Second Faculty of Medicine
- Outcome for Children and Young Adults With T-Cell ALL and Induction Failure in Contemporary Trials2023 | Second Faculty of Medicine
- Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine